First-trimester screening for trisomies in pregnancies with a vanishing twin.
To examine multiple of the median (MoM) levels of serum free β-hCG and PAPP-A in a large series of pregnancies with a vanishing twin, determine the association of these levels with the interval between embryonic death and blood sampling and develop a model that would allow incorporation of these metabolites in first-trimester combined screening for trisomies. This was a retrospective study comparing maternal serum free β-hCG and PAPP-A levels at 11-13 weeks' gestation in 528 dichorionic pregnancies with vanishing twins, including 194 (36.7%) with an empty gestational sac and 334 (63.3%) with a dead embryo, with levels in 5,280 normal singleton pregnancies matched for method of conception and date of examination. In the vanishing twins marker levels were examined in relation to the estimated time between embryonic death and maternal blood sampling. The main findings were: first, in vanishing twins the median free ß-hCG MoM was not significantly different from that of normal singleton pregnancies (1.000, 95% CI 0.985 - 1.0156, versus 0.995, 95% CI 0.948 - 1.044; p= 0.849), second, PAPP-A MoM was higher in vanishing twins than in normal singleton pregnancies (1.000, 95% CI 0.985 - 1.015), both in the group with an empty gestational sac (1.165, 95% CI 1.080 - 1.256; p=0.0001), and in those with a dead embryo (1.175, 95%CI 1.105 -1.249; p<0.0001), third, in vanishing twins with a dead embryo PAPP-A MoM was inversely related to the interval between estimated gestational age at embryonic demise and blood sampling (p<0001), fourth, in first-trimester screening for trisomy 21 in singleton pregnancies the estimated detection rate, at 5% false positive rate, was 82% in screening by a combination of maternal age and fetal NT and this increased to 86% with the addition of serum free ß-hCG and then to 91% with the addition of serum PAPP-A, and fifth, similar performance of screening can be achieved in vanishing twins, provided the appropriate adjustments are made in the level of PAPP-A for the interval between estimated gestational age at embryonic demise and blood sampling. First-trimester screening for trisomies in vanishing twins should rely on a combination of maternal age, fetal nuchal translucency thickness and serum free β-hCG, as in a singleton pregnancy, without the use of serum PAPP-A. Alternatively, PAPP-A can be included but only after appropriate adjustment for the interval between the estimated gestational age at fetal demise and blood sampling. This article is protected by copyright. All rights reserved.